Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
12 "Eun Young Lee"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Articles
Diabetes, obesity and metabolism
Big Data Articles (National Health Insurance Service Database)
The Triglyceride-Glucose Index and Risk of End-Stage Renal Disease across Different Durations of Type 2 Diabetes Mellitus: A Longitudinal Cohort Study
Mi-sook Kim, Kyu-Na Lee, Jeongmin Lee, Jeongeun Kwak, Seung-Hwan Lee, Hyuk-Sang Kwon, Jing Hughes, Kyung-Do Han, Eun Young Lee
Endocrinol Metab. 2025;40(5):718-726.   Published online May 19, 2025
DOI: https://doi.org/10.3803/EnM.2024.2271
  • 4,154 View
  • 93 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigated the association between the triglyceride-glucose (TyG) index, a marker of insulin resistance, and the risk of end-stage renal disease (ESRD) in individuals with type 2 diabetes mellitus (T2DM), focusing on variations by diabetes duration.
Methods
We analyzed 1,219,148 Korean adults with T2DM from National Health Insurance Service data who underwent biennial health evaluations (2015 to 2016). ESRD was defined using specific procedural codes (V codes), and Cox proportional hazard models were employed to estimate hazard ratios (HRs) for ESRD across TyG index quartiles and diabetes duration categories, adjusting for various confounders.
Results
Over 6,967,381 person-years of follow-up, 7,548 participants developed ESRD. Higher TyG index quartiles were independently associated with increased risk of ESRD, which was more pronounced with longer diabetes duration. The adjusted HR for ESRD in the highest TyG quartile (Q4) compared to the lowest quartile (Q1) was 1.235 (95% confidence interval [CI], 0.995 to 1.533) in new-onset diabetes, and 1.592 (95% CI, 1.465 to 1.730) in those with diabetes for ≥10 years. Compared to the lowest TyG quartile in new-onset diabetes, the adjusted HR for ESRD in the highest quartile with diabetes duration ≥10 years increased to 10.239 (95% CI, 8.440 to 12.422). Subgroup analysis revealed that a higher TyG index consistently increased the risk of ESRD, with stronger associations observed in younger individuals and those without comorbidities.
Conclusion
The TyG index is a significant predictor of ESRD in T2DM, particularly in those with prolonged diabetes duration. Targeting insulin resistance early may mitigate the risk of ESRD in this population.

Citations

Citations to this article as recorded by  
  • Association between TYG-BMI index and asthma in adults over 45 years of age: analysis of Global Burden of Disease 2021, China Health and Retirement Longitudinal Study, and National Health and Nutrition Examination Survey data
    Zhuolin Qin, Longqian Li, Cheng Wang
    Journal of Asthma.2026; 63(2): 214.     CrossRef
  • The Association Between the Triglyceride–Glucose Index and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
    Munther S. Momani, Raneem Dalaeen, Dia Sarhan, Zaid Sarhan, Suhib Awamleh, Yazan M. Momani, Omar Abu Farsakh
    Life.2026; 16(2): 345.     CrossRef
Close layer
Diabetes, obesity and metabolism
Big Data Articles (National Health Insurance Service Database)
Association between the Triglyceride-Glucose Index and Cardiovascular Risk and Mortality across Different Diabetes Durations: A Nationwide Cohort Study
Jeongeun Kwak, Kyung-Do Han, Eun Young Lee, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Jeongmin Lee
Endocrinol Metab. 2025;40(4):548-560.   Published online March 5, 2025
DOI: https://doi.org/10.3803/EnM.2024.2205
  • 4,829 View
  • 237 Download
  • 6 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
We aimed to assess the association between triglyceride-glucose (TyG) index and cardiovascular disease (CVD) risk and mortality in a large cohort of diabetes patients.
Methods
A retrospective cohort study of 1,090,485 participants from the Korean National Health Insurance Service database was conducted. Participants were stratified into TyG quartiles.
Results
Higher TyG index quartiles were significantly associated with an increased CVD risk and mortality risk. In fully adjusted models, participants in the highest TyG quartile (Q4) had an 18% higher risk of CVD (hazard ratio [HR], 1.18; 95% confidence interval [CI], 1.13 to 1.23) and a 16% higher risk of mortality (HR, 1.16; 95% CI, 1.11 to 1.23) compared to those in the lowest quartile (Q1). The association was particularly pronounced in patients with fasting glucose ≥126 mg/dL (CVD [HR, 1.33; 95% CI, 1.29 to 1.37], mortality [HR, 1.23; 95% CI, 1.20 to 1.26]; P for interaction <0.001). Patients with a diabetes duration of ≥10 years showed the strongest association between the TyG index and CVD risk (HR, 1.44; 95% CI, 1.38 to 1.50), while the mortality risk was particularly elevated in those with a diabetes duration of less than 5 years (HR, 1.23; 95% CI, 1.18 to 1.30). Subgroup analyses revealed stronger associations between TyG index and CVD risk in younger participants, non-obese individuals, and non-smokers.
Conclusion
The TyG index is a significant predictor of CVD and mortality in diabetic patients, particularly in those with poor glycemic control or longer disease duration.

Citations

Citations to this article as recorded by  
  • Preoperative triglyceride–glucose index as a metabolic predictor of surgical site infection after posterior lumbar fusion
    Yu Hua, Shaoxing Li, Yuan Jiang, Jinwang Liu
    Journal of Orthopaedic Surgery.2026;[Epub]     CrossRef
  • Combined effect of triglyceride-glucose index and glucose disposal rate on cardio-cerebrovascular disease
    Hongfei Yang, Chao Sun, Ya Li, You Zhou, Rui Wang, Yingxue Li, Marwan Salih Al-Nimer
    PLOS One.2026; 21(2): e0342154.     CrossRef
  • The Triglyceride-Glucose Index: A Practical Tool for Enhanced Cardiovascular Risk Stratification in Type 2 Diabetes
    Jang Won Son
    Endocrinology and Metabolism.2025; 40(4): 545.     CrossRef
  • The association between triglyceride-glucose index and all-cause/cardiovascular mortality in patients with different glucose metabolism statuses
    Jiajun Liu, Jinhua Kang, Pengpeng Liang, Zhangxiao Song, Guiyun Li, Xueshan Jin, Hongyan Wu
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Standardized Triglyceride-Glucose and Plasma Atherogenic Indices as Predictors of Diabetic Nephropathy and Coronary Artery Disease in Patients with Type 1 Diabetes Mellitus
    Nazif Yalçın, Nizameddin Koca
    European Journal of Therapeutics.2025;[Epub]     CrossRef
Close layer
Miscellaneous
Lipid Variability Induces Endothelial Dysfunction by Increasing Inflammation and Oxidative Stress
Marie Rhee, Joonyub Lee, Eun Young Lee, Kun-Ho Yoon, Seung-Hwan Lee
Endocrinol Metab. 2024;39(3):511-520.   Published online May 16, 2024
DOI: https://doi.org/10.3803/EnM.2023.1915
  • 6,616 View
  • 150 Download
  • 24 Web of Science
  • 25 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigates the impact of fluctuating lipid levels on endothelial dysfunction.
Methods
Human aortic and umbilical vein endothelial cells were cultured under varying palmitic acid (PA) concentrations: 0, 50, and 100 μM, and in a variability group alternating between 0 and 100 μM PA every 8 hours for 48 hours. In the lipid variability group, cells were exposed to 100 μM PA during the final 8 hours before analysis. We assessed inflammation using real-time polymerase chain reaction, Western blot, and cytokine enzyme-linked immunosorbent assay (ELISA); reactive oxygen species (ROS) levels with dichlorofluorescin diacetate assay; mitochondrial function through oxygen consumption rates via XF24 flux analyzer; and endothelial cell functionality via wound healing and cell adhesion assays. Cell viability was evaluated using the MTT assay.
Results
Variable PA levels significantly upregulated inflammatory genes and adhesion molecules (Il6, Mcp1, Icam, Vcam, E-selectin, iNos) at both transcriptomic and protein levels in human endothelial cells. Oscillating lipid levels reduced basal respiration, adenosine triphosphate synthesis, and maximal respiration, indicating mitochondrial dysfunction. This lipid variability also elevated ROS levels, contributing to a chronic inflammatory state. Functionally, these changes impaired cell migration and increased monocyte adhesion, and induced endothelial apoptosis, evidenced by reduced cell viability, increased BAX, and decreased BCL2 expression.
Conclusion
Lipid variability induce endothelial dysfunction by elevating inflammation and oxidative stress, providing mechanistic insights into how lipid variability increases cardiovascular risk.

Citations

Citations to this article as recorded by  
  • NLRP3 inhibition protects human coronary endothelial cells from oxidative and lipotoxic stress
    Astrid Parenti, Costanza Titi, Arianna Brovero, Federica Blua, Francesca Boccato, Angela Silvano, Francesco Fedele, Anna Vittoria Mattioli, Massimo Bertinaria, Pasquale Pagliaro, Claudia Penna
    Biochemical Pharmacology.2026; 244: 117615.     CrossRef
  • Lipid dysregulation in renal cancer: Drivers of tumor growth and determinants of treatment-induced toxicity
    Mohammed Alnukhali, Alessia Fornoni, Alan Pollack, Anis Ahmad
    Seminars in Cancer Biology.2026; 119: 54.     CrossRef
  • Mitochondrial Dysfunction in Inflammatory Skin Diseases: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies
    Mei Li, Guowei Zhao, Guo‐wei Zhao, Jie Shen
    Drug Development Research.2026;[Epub]     CrossRef
  • A Review of Emerging Biomarkers Connecting Diabetes and Ischemic Stroke: Implications for Early Detection and Risk Stratification
    Nadia Hussain, Azza Ramadan, Amal Hussain Ibrahim Al Haddad, Zina Alfahl, Kenneth Lo
    Journal of Diabetes Research.2026;[Epub]     CrossRef
  • Roles of Catecholamines and Inflammation in Endothelial Dysfunction: a Study Using Takotsubo Syndrome Patient-specific hiPSC-ECs
    Guoqiang Yang, Luyi Zhong, Jiayue Wang, Chenyu Yang, Lukas Cyganek, Nazha Hamdani, Xiaobo Zhou, Xuehui Fan, Ibrahim El-Battrawy, Ibrahim Akin
    Stem Cell Reviews and Reports.2026;[Epub]     CrossRef
  • Emerging regulators of endothelial lipid metabolism in atherosclerosis
    Jason S. Irei, Kai Hirayama, William A. Boisvert
    Current Opinion in Lipidology.2026;[Epub]     CrossRef
  • Association between triglyceride glucose index-related indices and kidney stones in adults based on NHANES 2007–2020
    Ming Liu, Ping Yang, Yunpeng Gou
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The Impact of Modifiable Risk Factors on the Endothelial Cell Methylome and Cardiovascular Disease Development
    Hashum Sum, Alison C. Brewer
    Frontiers in Bioscience-Landmark.2025;[Epub]     CrossRef
  • A retrospective study on the correlation between antibody levels and endothelial function in SLE patients: An analysis based on ultrasound and serum biomarkers
    Huan Xia, Zaixing Pan, Yun Hong, Qingzhu Zhao, Weili Fan
    Molecular Immunology.2025; 181: 66.     CrossRef
  • Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
    Hygerta Berisha, Reham Hattab, Laura Comi, Claudia Giglione, Silvia Migliaccio, Paolo Magni
    Nutrients.2025; 17(5): 776.     CrossRef
  • Mitochondria‑derived peptides: Promising microproteins in cardiovascular diseases (Review)
    Yutong Ran, Zhiliang Guo, Lijuan Zhang, Hong Li, Xiaoyun Zhang, Xiumei Guan, Xiaodong Cui, Hao Chen, Min Cheng
    Molecular Medicine Reports.2025; 31(5): 1.     CrossRef
  • Long-term cardiovascular risk and mortality associated with uric acid to HDL-C ratio: a 20-year cohort study in adults over 40
    Ying Cui, Wen Zhang
    Scientific Reports.2025;[Epub]     CrossRef
  • Dapagliflozin prevents vascular ischemia-reperfusion injury in healthy young males: a randomized, placebo-controlled, double-blinded trial
    Martin Lutnik, Stefan Weisshaar, Brigitte Litschauer, Michaela Bayerle-Eder, Jan Niederdöckl, Michael Wolzt
    Scientific Reports.2025;[Epub]     CrossRef
  • Crucial roles of calcium ATPases and phosphoinositides: Insights into pathophysiology and therapeutic strategies
    Hyun-Oh Gu, Seung Wan Noh, Ok-Hee Kim, Byung-Chul Oh
    Molecules and Cells.2025; 48(9): 100254.     CrossRef
  • Endothelial dysfunction in atherosclerosis: from classical pathways to emerging mechanisms
    Yuyao Feng, Chenyang Li, Junye Chen, Xingqi Xiao, Qilong Mao, Hongmei Zhao, Jing Wang, Bao Liu
    Vessel Plus.2025;[Epub]     CrossRef
  • RNF213-Related Vasculopathy: An Entity with Diverse Phenotypic Expressions
    Takeshi Yoshimoto, Sho Okune, Shun Tanaka, Hiroshi Yamagami, Yuji Matsumaru
    Genes.2025; 16(8): 939.     CrossRef
  • Comparative hepatotoxicity of HFPO-TA and PFOA in Opsariichthys bidens: Greater liver injury induced by the PFOA alternative
    Zhenlan Xu, Zhengzheng Liu, Tao Tang, Dou Wang, Lu Lv, Jinsong Liu, Xinquan Wang, Yanhua Wang
    Environmental Pollution.2025; 386: 127216.     CrossRef
  • Advances in Mitochondrial Dysfunction and Its Role in Cardiovascular Diseases
    Yan Qiu, Shuo Chang, Ye Zeng, Xiaoqi Wang
    Cells.2025; 14(20): 1621.     CrossRef
  • The Systemic Link Between Oral Health and Cardiovascular Disease: Contemporary Evidence, Mechanisms, and Risk Factor Implications
    Florinel Cosmin Bida, Florin Razvan Curca, Raoul-Vasile Lupusoru, Dragos Ioan Virvescu, Mihaela Scurtu, Gabriel Rotundu, Oana Maria Butnaru, Teona Tudorici, Ionut Luchian, Dana Gabriela Budala
    Diseases.2025; 13(11): 354.     CrossRef
  • Extra Virgin Olive Oil (EVOO) Improves Vascular Endothelial Function and Hemodynamic Parameters in Patients with Hyperlipidemia: A Post Hoc Analysis of a Randomized Controlled Trial
    Christos Kourek, Emmanouil Makaris, Vassiliki Benetou, Prokopios Magiatis, Virginia Zouganeli, Stavros Dimopoulos, Georgios Georgiopoulos, Alexandros Briasoulis, Ioannis Paraskevaidis, Eleni Melliou, Philippos Orfanos
    Nutrients.2025; 17(23): 3650.     CrossRef
  • Peripheral artery disease and local drug delivery: a review of disease pathology and drug delivery systems for therapy below the knee
    Nicole M. Akers, Tammy R. Dugas
    Experimental Biology and Medicine.2025;[Epub]     CrossRef
  • Palmitic but Not Oleic Acid Induces Pro-Inflammatory Dysfunction of Human Endothelial Cells from Different Vascular Beds In Vitro
    Daria Shishkova, Victoria Markova, Yulia Yurieva, Alexey Frolov, Anastasia Lazebnaya, Maxim Sinitsky, Anna Sinitskaya, Vera Matveeva, Evgenia Torgunakova, Alexander Stepanov, Anna Malashicheva, Asker Khapchaev, Nikita Podkuychenko, Alexander Vorotnikov, V
    International Journal of Molecular Sciences.2025; 26(24): 12148.     CrossRef
  • Can Daily Dietary Choices Have a Cardioprotective Effect? Food Compounds in the Prevention and Treatment of Cardiometabolic Diseases
    Elżbieta Szczepańska, Barbara Janota, Marika Wlazło, Magdalena Gacal
    Metabolites.2024; 14(6): 296.     CrossRef
  • Lipid Swings Provoke Vascular Inflammation
    Jae-Han Jeon
    Endocrinology and Metabolism.2024; 39(3): 448.     CrossRef
  • Relationship between Oral Lichen Planus and Cardiovascular Disease of Atherosclerotic Origin: Systematic Review and Meta-Analysis
    Beatriz Gonzalez Navarro, Sonia Egido Moreno, Carlos Omaña Cepeda, Albert Estrugo Devesa, Enric Jane Salas, Jose Lopez Lopez
    Journal of Clinical Medicine.2024; 13(16): 4630.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and Inflammation
Kyung Bong Ha, Weerapon Sangartit, Ah Reum Jeong, Eun Soo Lee, Hong Min Kim, Soyeon Shim, Upa Kukongviriyapan, Dae-Kee Kim, Eun Young Lee, Choon Hee Chung
Endocrinol Metab. 2022;37(1):96-111.   Published online February 28, 2022
DOI: https://doi.org/10.3803/EnM.2021.1305
  • 8,876 View
  • 238 Download
  • 11 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Diabetic nephropathy (DN) is characterized by albuminuria and accumulation of extracellular matrix (ECM) in kidney. Transforming growth factor-β (TGF-β) plays a central role in promoting ECM accumulation. We aimed to examine the effects of EW-7197, an inhibitor of TGF-β type 1 receptor kinase (ALK5), in retarding the progression of DN, both in vivo, using a diabetic mouse model (db/db mice), and in vitro, in podocytes and mesangial cells.
Methods
In vivo study: 8-week-old db/db mice were orally administered EW-7197 at a dose of 5 or 20 mg/kg/day for 10 weeks. Metabolic parameters and renal function were monitored. Glomerular histomorphology and renal protein expression were evaluated by histochemical staining and Western blot analyses, respectively. In vitro study: DN was induced by high glucose (30 mM) in podocytes and TGF-β (2 ng/mL) in mesangial cells. Cells were treated with EW-7197 (500 nM) for 24 hours and the mechanism associated with the attenuation of DN was investigated.
Results
Enhanced albuminuria and glomerular morphohistological changes were observed in db/db compared to that of the nondiabetic (db/m) mice. These alterations were associated with the activation of the TGF-β signaling pathway. Treatment with EW-7197 significantly inhibited TGF-β signaling, inflammation, apoptosis, reactive oxygen species, and endoplasmic reticulum stress in diabetic mice and renal cells.
Conclusion
EW-7197 exhibits renoprotective effect in DN. EW-7197 alleviates renal fibrosis and inflammation in diabetes by inhibiting downstream TGF-β signaling, thereby retarding the progression of DN. Our study supports EW-7197 as a therapeutically beneficial compound to treat DN.

Citations

Citations to this article as recorded by  
  • Mosla chinensis Maxim extracts exert anti-inflammatory, antioxidant, and antifibrotic effects in silicosis
    Shao-Tung Wu, Cheng-Wei Huang, Tsung-Han Lee, Hui-Chun Ku
    Journal of Ethnopharmacology.2026; 358: 121047.     CrossRef
  • Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease
    Jae Hyun Byun, Paul F. Lebeau, Jackie Trink, Nikhil Uppal, Matthew B. Lanktree, Joan C. Krepinsky, Richard C. Austin
    Nature Reviews Nephrology.2025; 21(5): 299.     CrossRef
  • Targeting endoplasmic reticulum stress: an innovative therapeutic strategy for podocyte-related kidney diseases
    Jiao Lv, Honghai Yu, Sasa Du, Pengyu Xu, Yunyun Zhao, Wenxiu Qi, Xiuge Wang
    Journal of Translational Medicine.2025;[Epub]     CrossRef
  • Evaluation of the novel ALK5 inhibitor EW-7197 on therapeutic efficacy in renal fibrosis using a three-dimensional chip model
    So Young Jang, Seong-Hye Hwang, Yunyeong Choi, Wan-Young Kim, Sung Hyuk Park, Won Mook Kim, Eun-Jeong Kwon, Sejoong Kim
    Kidney Research and Clinical Practice.2025; 44(4): 612.     CrossRef
  • Combination of THU/ALK-5i exhibits profound anti-MASH activity through suppression of lipogenesis and fibrogenesis
    Kampeebhorn Boonloh, Eun Soo Lee, Su Ho Jo, Na Won Park, So Bin Lee, Choon Hee Chung
    Scientific Reports.2025;[Epub]     CrossRef
  • CD163 and TYROBP Are Two Therapeutic Targets for Hyperglycemia‐Induced Mesangial Cell Stress
    Zhang Ran, Zhang Guiling, Fan Yanna, Luo Laimin
    Chemical Biology & Drug Design.2025;[Epub]     CrossRef
  • TGF-β signaling in health, disease and therapeutics
    Ziqin Deng, Tao Fan, Chu Xiao, He Tian, Yujia Zheng, Chunxiang Li, Jie He
    Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
  • Endoplasmic Reticulum Stress-Mediated Cell Death in Renal Fibrosis
    Shangze Guo, Yinghao Tong, Ting Li, Kexin Yang, Wei Gao, Fujun Peng, Xiangyu Zou
    Biomolecules.2024; 14(8): 919.     CrossRef
  • Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
    Qi Jin, Tongtong Liu, Yuan Qiao, Donghai Liu, Liping Yang, Huimin Mao, Fang Ma, Yuyang Wang, Liang Peng, Yongli Zhan
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis
    Kyung Bong Ha, Eun Soo Lee, Na Won Park, Su Ho Jo, Soyeon Shim, Dae-Kee Kim, Chan Mug Ahn, Choon Hee Chung
    Diabetes & Metabolism Journal.2023; 47(4): 500.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Tetrahydrocurcumin Ameliorates Kidney Injury and High Systolic Blood Pressure in High-Fat Diet-Induced Type 2 Diabetic Mice
Weerapon Sangartit, Kyung Bong Ha, Eun Soo Lee, Hong Min Kim, Upa Kukongviriyapan, Eun Young Lee, Choon Hee Chung
Endocrinol Metab. 2021;36(4):810-822.   Published online August 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.988
  • 7,881 View
  • 195 Download
  • 14 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Activation of the intrarenal renin-angiotensin system (RAS) is implicated in the pathogenesis of kidney injury and hypertension. We aimed to investigate the protective effect of tetrahydrocurcumin (THU) on intrarenal RAS expression, kidney injury, and systolic blood pressure (SBP) in high-fat diet (HFD)-induced type 2 diabetic mice.
Methods
Eight-week-old male mice were fed a regular diet (RD) or HFD for 12 weeks, and THU (50 or 100 mg/kg/day) was intragastrically administered with HFD. Physiological and metabolic changes were monitored and the expression of RAS components and markers of kidney injury were assessed.
Results
HFD-fed mice exhibited hyperglycemia, insulin resistance, and dyslipidemia compared to those in the RD group (P<0.05). Kidney injury in these mice was indicated by an increase in the ratio of albumin to creatinine, glomerular hypertrophy, and the effacement of podocyte foot processes. Expression of intrarenal angiotensin-converting enzyme, angiotensin II type I receptor, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-4, and monocyte chemoattractant protein-1 was also markedly increased in HFD-fed mice. HFD-fed mice exhibited elevated SBP that was accompanied by an increase in the wall thickness and vascular cross-sectional area (P<0.05), 12 weeks post-HFD consumption. Treatment with THU (100 mg/kg/day) suppressed intrarenal RAS activation, improved insulin sensitivity, and reduced SBP, thus, attenuating kidney injury in these mice.
Conclusion
THU alleviated kidney injury in mice with HFD-induced type 2 diabetes, possibly by blunting the activation of the intrarenal RAS/nicotinamide adenine dinucleotide phosphate oxidase IV (NOX4)/monocyte chemoattractant protein 1 (MCP-1) axis and by lowering the high SBP.

Citations

Citations to this article as recorded by  
  • Synthetic curcumin analogs in nephrotoxicity: Mechanisms and therapeutic advances
    Farzaneh Hayati, Sahar Ghoflchi, Asie Sadeghi, Prashant Kesharwani, Amirhossein Sahebkar, Hossein Hosseini
    Food and Chemical Toxicology.2026; 209: 115921.     CrossRef
  • NOX4-mediated oxidative stress in diabetic complications: Potential of natural products
    Sachin Sharma, Ashwani Mittal, Manjusha Choudhary
    Pharmacological Research - Natural Products.2026; 10: 100515.     CrossRef
  • Tetrahydrocurcumin alleviates di-(2-ethylhexyl) phthalate-induced adipose tissue dysfunction and testicular toxicity in adult mice: possible involvement of adiponectin-adipoR signaling in the testis
    Choirul Anwar, Yu-Chi Chu, Mei-Ling Tsai, Chi-Tang Ho, Ching-Shu Lai
    Food & Function.2025; 16(2): 583.     CrossRef
  • Repurposing Nano Curcumin: Unveiling its Therapeutic Potential in Diabetic Nephropathy
    Rarchita Sharma, Yogesh Mali, Yogeeta. O. Agrawal, Vinit V. Agnihotri, Sameer N. Goyal
    Current Drug Targets.2025; 26(5): 298.     CrossRef
  • Research Progress on the Antioxidant Activity of Natural Diarylheptanoids: Mechanisms and Structure–activity Relationships
    An-Na Ma, Tie Yao, Ya-Jing Guo, Chong-Yan Zhao, Bing-jie Wang, Gen Li, Feng Qiu
    Current Medicinal Chemistry.2025; 32(13): 2494.     CrossRef
  • Research and advances in mouse models of diabetic nephropathy: a narrative review
    Kang Xie, Yan Ma, Jingjing Din, Yujie Jin, Siwen Zhang, Shiqiang Liu, Cui Yu, Xu Wu, Chunyan Xing, Lizhuo Wang, Jialin Gao
    BMC Nephrology.2025;[Epub]     CrossRef
  • Topical Application of miR-200b-3p by Poloxamer 407-Based Hydrogel Accelerates Diabetic Wound Healing
    Wan-Yu Lo, Cian-Huei Sin, Huang-Joe Wang
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 3845.     CrossRef
  • Combination of THU/ALK-5i exhibits profound anti-MASH activity through suppression of lipogenesis and fibrogenesis
    Kampeebhorn Boonloh, Eun Soo Lee, Su Ho Jo, Na Won Park, So Bin Lee, Choon Hee Chung
    Scientific Reports.2025;[Epub]     CrossRef
  • The role of tetrahydrocurcumin in disease prevention and treatment
    Mengting Zhou, Rui Li, Hua Hua, Ying Dai, Zhujun Yin, Li Li, Jin Zeng, Mengni Yang, Junning Zhao, Ruirong Tan
    Food & Function.2024; 15(13): 6798.     CrossRef
  • The Development of Dyslipidemia in Chronic Kidney Disease and Associated Cardiovascular Damage, and the Protective Effects of Curcuminoids
    Zeltzin Alejandra Ceja-Galicia, Ana Karina Aranda-Rivera, Isabel Amador-Martínez, Omar Emiliano Aparicio-Trejo, Edilia Tapia, Joyce Trujillo, Victoria Ramírez, José Pedraza-Chaverri
    Foods.2023; 12(5): 921.     CrossRef
  • Translation Animal Models of Diabetic Kidney Disease: Biochemical and Histological Phenotypes, Advantages and Limitations
    Wenting Luo, Shiyun Tang, Xiang Xiao, Simin Luo, Zixuan Yang, Wei Huang, Songqi Tang
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1297.     CrossRef
  • Curcumin ameliorates focal segmental glomerulosclerosis by inhibiting apoptosis and oxidative stress in podocytes
    Hui Zhang, Qing-Qing Dong, Hua-Pan Shu, Yu-Chi Tu, Qian-Qian Liao, Li-Jun Yao
    Archives of Biochemistry and Biophysics.2023; 746: 109728.     CrossRef
  • An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy
    Xiaoyu Zhu, Xingli Xu, Chigang Du, Yanping Su, Lixue Yin, Xiaoqiu Tan, Hui Liu, Yiru Wang, Lei Xu, Xinghua Xu
    Biomedicine & Pharmacotherapy.2022; 153: 113438.     CrossRef
  • An integrated bioinformatics analysis and experimental study identified key biomarkers CD300A or CXCL1, pathways and immune infiltration in diabetic nephropathy mice
    WEI LIANG, QIANG LUO, ZONGWEI ZHANG, KEJU YANG, ANKANG YANG, QINGJIA CHI, HUAN HU
    BIOCELL.2022; 46(8): 1989.     CrossRef
Close layer
Case Reports
1-34 PTH Could Reverse Impaired Bone Mineralization Induced By the Overdose of Bisphosphonate.
Kyeong Hye Park, Kwang Joon Kim, Han Seok Choi, Kyoung Min Kim, Eun Young Lee, Seonhui Han, Hyun Sil Kim, Daham Kim, Hannah Seok, Eun Yeong Choe, Yumie Rhee, Sung Kil Lim
Endocrinol Metab. 2012;27(3):247-250.   Published online September 19, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.3.247
  • 13,585 View
  • 28 Download
AbstractAbstract PDF
Bisphosphonates are the mainstay of osteoporosis treatment. Despite the fact that bisphosphonates have a relatively good safety record and are tolerated well by the majority of patients, serious adverse events have been associated with their use. A 41-year-old man had been diagnosed with osteoporosis and had taken etidronate 200 mg/day daily for 2 years due to the judgmental error. He was referred for the management of refractory bone pain and generalized muscle ache. Serum calcium, phosphate, 25-hydroxy-vitamin D (25(OH)D), and immunoreactive parathyroid hormone (iPTH) were within normal range. Plain X-ray showed multiple fractures. Whole body bone scan confirmed multiple sites of increased bone uptakes. Tetracycline-labeled bone biopsy showed typical findings of osteomalacia. He was diagnosed with iatrogenic, etidronate-induced osteomalacia. The patient received daily parathyroid hormone (PTH) injection for 18 months. PTH effectively reverses impaired bone mineralization caused by etidronate misuse. Currently, he is doing well without bone pain. Bone mineral density significantly increased, and the increased bone uptake was almost normalized after 18 months. This case seems to suggest that human PTH (1-34) therapy, possibly in association with calcium and vitamin D, is associated with important clinical improvements in patients with impaired bone mineralization due to the side effect of bisphosphonate.
Close layer
A Case of Pituitary Adenoma with Simultaneous Secretion of TSH and GH.
Eun Young Lee, Cheol Ryong Ku, Hyun Min Kim, Woo Kyoung Lee, Jung Soo Lim, Sena Hwang, Do Hwan Kim, Dong Yeob Shin, Eun Jig Lee
Endocrinol Metab. 2011;26(2):160-165.   Published online June 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.2.160
  • 4,409 View
  • 38 Download
  • 2 Crossref
AbstractAbstract PDF
Thyrotropin (TSH)-secreting pituitary adenoma is a very rare disease. In one-quarter of patients suffering from this disease, the pituitary tumor secretes other anterior pituitary hormones. Herein, we report a case of pituitary adenoma with simultaneous secretion of TSH and growth hormone (GH). A 34-year-old female visitied local hospital complaining of sweating, intermittent palpitation, and weight loss of 8 kg within 1 year. The patient had undergone trans-sphenoidal surgery 3 years prior for resolution of a TSH and GH co-secreting pituitary adenoma. She had been administered somatostatin analogue prior to visiting our hospital. The patient's GH levels were suppressed to below 1 ng/mL on the 75 g oral glucose tolerance test, and her basal insulin-like growth factor-I (IGF-I) level was within normal range. Thyroid function tests demonstrated increased levels of both free thyroxine and TSH. Sella-MRI revealed pituitary adenoma at the floor of the pituitary fossa, approximately 2 cm in height. Therefore, she was diagnosed with residual TSH-secreting pituitary adenoma. The patient again underwent trans-sphenoidal surgery and entered complete remission, based on hormone levels and MRI findings.

Citations

Citations to this article as recorded by  
  • Endoscopic Transsphenoidal Surgery of Pituitary Adenomas: Preliminary Results of the Neurosurgery Service of Hospital Cristo Redentor
    Gerson Perondi, Afonso Mariante, Fernando Azambuja, Gabriel Frizon Greggianin, Wanderson William dos Santos Dias, Giulia Pinzetta
    Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery.2023; 42(02): e89.     CrossRef
  • A case of a co-secreting TSH and growth hormone pituitary adenoma presenting with a thyroid nodule
    Laura Hamilton Adams, Derick Adams
    Endocrinology, Diabetes & Metabolism Case Reports.2018;[Epub]     CrossRef
Close layer
Primary Bilateral Adrenal Non-Hodgkin's Lymphoma Presented with Adrenal Insufficiency: A Case Report.
Eun Young Lee, Kyoung Min Kim, Kwang Joon Kim, Songmi Noh, Jin Seok Kim, Woo Ik Yang, Sung Kil Lim
Endocrinol Metab. 2011;26(1):101-105.   Published online March 1, 2011
DOI: https://doi.org/10.3803/EnM.2011.26.1.101
  • 3,109 View
  • 27 Download
  • 1 Crossref
AbstractAbstract PDF
Primary adrenal lymphoma is a very rare disease and it is known to have a poor prognosis. We report here on a case of primary adrenal insufficiency that was secondary to primary bilateral adrenal lymphoma. A 54-year old man was hospitalized because of easy fatigability, weight loss and consistent malaise for 6 months. The physical examination revealed hyperpigmentation on the anterior chest and hypotension. According these findings and symptoms, we did a rapid ACTH stimulation test with a clinical suspicion of adrenal insufficiency. He showed an inadequate adrenal response and so he was diagnosed with adrenal insufficiency. The abdominal CT images showed bilateral huge adrenal masses and increased uptake of the adrenal glands on PET. The pathologic diagnosis by ultrasound-guided gun biopsy of the right adrenal gland was diffuse large B cell lymphoma. The patient was administered combination chemotherapy with the R-CHOP regimen, and after 8-cycles of chemotherapy, he achieved complete remission of tumor according to the image studies and he recovered his adrenal function. Primary adrenal lymphoma, although a rare disease, should be considered in patients with bilateral enlargement of the adrenal glands and when the adrenal glands show increased uptake on a PET scan, and especially there is adrenal insufficiency.

Citations

Citations to this article as recorded by  
  • Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review
    John Xie, Albert Jang, Motohide Uemura, Shigeaki Nakazawa, Teresa Calimeri, Andres JM Ferreri, Shuang R. Chen, Janet L. Schmid, Theresa C. Brown, Francisco Socola, Hana Safah, Nakhle S. Saba
    Leukemia Research Reports.2021; 16: 100263.     CrossRef
Close layer
Original Articles
Correlation between Pituitary Insufficiency and Magnetic Resonance Imaging Finding in Non-Functioning Pituitary Adenomas.
Hyun Min Kim, Cheol Ryong Ku, Eun Young Lee, Woo Kyung Lee, Jung Soo Lim, Sena Hwang, Mi Jung Lee, Seung Ku Lee, Sun Ho Kim, Eun Jig Lee
Endocrinol Metab. 2010;25(4):310-315.   Published online December 1, 2010
DOI: https://doi.org/10.3803/EnM.2010.25.4.310
  • 3,370 View
  • 34 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Non-functioning pituitary adenomas (NFPAs) are characterized by the absence of clinical and biochemical evidence of pituitary hormone hypersecretion, and these tumors constitute approximately one third of all the tumors of the anterior pituitary. Recently, hormonal deficiencies have gradually evolved to become the leading presenting signs and symptoms in patients with NFPAs. We investigated pituitary hormonal insufficiencies according to the magnetic resonance imaging (MRI) findings in patients with NFPA. METHODS: We evaluated the patients who were newly diagnosed with NFPA from 1997 through 2009. Among them, we analyzed 387 patients who were tested for their combined pituitary function and who underwent MRI. The severity of the hypopituitarism was determined by the number of deficient axes of the pituitary hormones. On the MRI study, the maximal diameter of the tumor, Hardy's classification, the thickness of the pituitary gland and the presence of stalk compression were evaluated. RESULTS: The mean age was 46.85 +/- 12.93 years (range: 15-86) and 186 patients (48.1%) were male. As assessed on MRI, the tumor diameter was 27.87 +/- 9.93 mm, the thickness of the normal pituitary gland was 1.42 +/- 2.07 mm and stalk compression was observed in 201 patients (51.9%). Hypopituitarism was observed in 333 patients (86.0%). Deficiency for each pituitary hormone was most severe in the patients with Hardy type IIIA. Hypopituitarism was severe in the older age patients (P = 0.001) and the patients with a bigger tumor size (P < 0.001) and the presence of stalk compression (P < 0.001). However, the patients who had a thicker pituitary gland showed less severe hypopituitarism (P < 0.001). Multivariate analysis showed that age, tumor diameter and the thickness of pituitary gland were important determinants for pituitary deficiency (P = 0.004, P < 0.001, P = 0.022, respectively). CONCLUSION: The results suggest that the hormonal deficiencies in patient with NFPA were correlated with the MRI findings, and especially the tumor diameter and preservation of the pituitary gland.

Citations

Citations to this article as recorded by  
  • Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas
    Daham Kim, Cheol Ryong Ku, Se Hee Park, Ju Hyung Moon, Eui Hyun Kim, Sun Ho Kim, Eun Jig Lee
    World Neurosurgery.2018; 115: e464.     CrossRef
Close layer
p53, p21 and bcl-2 Protein Expressions and the Clinical Significance in Papillary Thyroid Carcinoma.
Tae Sik Jung, Keun Sook Kim, Young Lyun Oh, Jung Hwa Jung, Eun Young Lee, Hye Seung Jung, Yong Ki Min, Myung Shik Lee, Moon Kyu Lee, Kwang Won Kim, Jae Hoon Chung
J Korean Endocr Soc. 2007;22(2):98-104.   Published online April 1, 2007
DOI: https://doi.org/10.3803/jkes.2007.22.2.98
  • 3,045 View
  • 19 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
There have been some investigations concerning the role of p53, p21 and bcl-2 protein expressions for the tumorigenesis of thyroid cancer. It had been debated that these protein expressions were associated with aggressive features of papillary thyroid carcinoma. We studied to evaluate the prevalence of these protein expressions and their clinical significances in papillary thyroid carcinoma. METHODS: We selected 49 patients with papillary thyroid carcinoma who had been operated on at Samsung Medical Center during the last 10 years. Immunohistochemical staining for p53, p21 and bcl-2 was done by the use of paraffin embedded tissues. We analyzed the results of immunohistochemical staining for p53, p21 and bcl-2 and the correlation with the patients' age, gender, tumor size, multifocality, tumor invasion to both lobes, extrathyroidal invasion, cervical lymph node invasion, distant metastasis and the clinical outcomes. RESULTS: Immunohistochemical staining for p53 was positive in 10 patients (20%), p21 was positive in 36 patients (73%) and bcl-2 was positive in 18 patients (37%). The p53 and bcl-2 expressions were not associated with the clinical parameters. Tumor multifocality and extrathyroidal invasion were significantly higher in the p21 positive group (both P < 0.05). CONCLUSION: This study showed that the p21 protein expression was associated with tumor multifocality and extrathyroidal invasion in the patients with papillary thyroid carcinoma. Immunohistochemical stains for p21 may be used as a parameter for tumor aggressiveness in papillary thyroid carcinoma.

Citations

Citations to this article as recorded by  
  • Clinicopathologic and Diagnostic Significance of p53 Protein Expression in Papillary Thyroid Carcinoma
    Mi Kyung Shin, Jeong Won Kim
    Asian Pacific Journal of Cancer Prevention.2014; 15(5): 2341.     CrossRef
Close layer
Case Reports
A case of Methimazole-Induced Cholestatic Jaundice With Agranulocytosis.
Sang Gu Kang, Jong Oh Bae, Eun Young Lee, Seong Min Lim, Sang Kun Cho, Ji Hye Kim, Sun Kyung Song
J Korean Endocr Soc. 2005;20(5):519-523.   Published online October 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.5.519
  • 3,447 View
  • 31 Download
  • 2 Crossref
AbstractAbstract PDF
Methimazole is a widely used and generally well-tolerated antithyroid agent. Adverse reactions occur in 1~5% of patients taking methimazole medication, but these are most commonly transient, benign leukopenia and a skin rash. Severe cholestatic jaundice, combined with agranulocytosis, has been known as a rare complication. Herein, a case of methimazole induced cholestatic jaundice, with agranulocytosis, is reported.

Citations

Citations to this article as recorded by  
  • A Case Report of Methimazole-Induced Acute Liver Failure Successfully Treated with Liver Transplantation
    Sung Jin Jeon, Tae Yong Kim, Seung-Hoon Lee, Jong Sik Kang, Gwang Hyeon Choi, Seung-Gyu Lee, Hee Sang Hwang
    Korean Journal of Medicine.2012; 83(3): 363.     CrossRef
  • A Case of Methimazole-induced Pancytopenia: Successful Treatment with Recombinant Human Granulocyte Colony-stimulating Factor
    Joo Hyoung Lee, Jihyun Lee, Sang Hun Sung, Sung Hwa Bae, Sang Gyung Kim, Hoon Kyu Oh
    Journal of Korean Endocrine Society.2006; 21(6): 548.     CrossRef
Close layer
Upper Airway Obstruction Caused by Intratracheal Ectopic Thyroid Tissue during Pregnancy.
Eun Young Lee, Byung Wan Lee, Jhingook Kim, Sung Jin Bae, Tae Sik Jung, Hye Seung Jung, Yong Ki Min, Myung Shik Lee, Moon Kyu Lee, Kwang Won Kim, Jae Hoon Chung
J Korean Endocr Soc. 2005;20(4):413-420.   Published online August 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.4.413
  • 3,072 View
  • 23 Download
  • 1 Crossref
AbstractAbstract PDF
Herein is report an extremely rare case of an intratracheal ectopic thyroid gland related with pregnancy. A 34-year-old woman, in gestational week 11, presented with stridor, progressive dyspnea and a choking sensation during her second pregnancy. Computed tomography of the neck and chest revealed a round intratracheal mass obstructing the airway. A bronchoscopic biopsy with LASER cauterization was performed, and the histological finding revealed normal thyroid tissue. The external thyroid of the patient was evaluated, but only found benign nodules in the thyroid gland. She underwent a segmental resection of the trachea, including the mass and the 1st tracheal cartilage. The histological findings revealed the intratracheal mass to be composed of benign thyroid tissue with nodular hyperplasia. After surgery, no pulmonary symptoms were evident. This case suggested the effect of pregnancy on thyroid tissue stimulatied due to a combination of an increasing human chorionic gonadotropin(hCG) level and relative iodine deficiency during pregnancy. This is the first report on the detection of intratracheal ectopic thyroid tissue during pregnancy in Korea.

Citations

Citations to this article as recorded by  
  • A case of mediastinal ectopic thyroid presenting with a paratracheal mass
    Eun Roh, Eun Shil Hong, Hwa Young Ahn, So-Yeon Park, Ho Il Yoon, Kyong Soo Park, Young Joo Park
    The Korean Journal of Internal Medicine.2013; 28(3): 361.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP